peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

somatostatin analog

Pasireotide

Published evidence · coverage incomplete
Anatomical contextAnatomy connections are not mapped yet.

No body region is highlighted until this profile has a supported anatomical connection. This does not mean the peptide has no biological effects.

Read published mechanism findings ↓

At a glance

What is it—and why does it matter?

Pasireotide long-acting release (LAR) is described as a multiligand somatostatin receptor ligand (it binds multiple somatostatin receptor subtypes).

Sources for this introduction: [1]

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

Identity

Pasireotide long-acting release (LAR) is described as a multiligand somatostatin receptor ligand (it binds multiple somatostatin receptor subtypes).

Sources[1]pubmedCurrent treatment landscape of acromegaly.Pasireotide long-acting release, a somatostatin receptor multiligand,
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “Pasireotide long-acting release, a somatostatin receptor multiligand,”

    Current treatment landscape of acromegaly. · Abstract

    pubmed:41965092:dfc997f88f44:dfc997f88f44

How does it work?

Target, response, and disposition.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
  • 42 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (28), assurance_score_below_0.72 (13), current_regulatory_source_required (6), extraction_ambiguity (33), extraction_confidence_not_high (1), high_risk_requires_regulatory_or_two_independent_sources (14), no_direct_support (41)

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. Current treatment landscape of acromegaly. ↗

    pubmed · published 2026-06-04 · retrieved 2026-08-24T17:38:00Z

Publication history and provenance

Version 2 · Automated assessment · 2026-08-28T12:18:09Z

096c114e93cede0c64d7fd04b6a94cb1c2cbff932f97486527dee6139f9fdf05